Clearstead Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.56K	Hold	3,200	–	–	﹤0.01%	1851
2025 Q4	$4.16K	Sell	3,200 -1,561	-33%	-$1.93K	﹤0.01%	2048
2025 Q3	$6K	Buy	4,761 +1,561	+49%	+$2.48K	﹤0.01%	2088
2025 Q2	$6.62K	Hold	3,200	–	–	﹤0.01%	2024
2025 Q1	$7.04K	Hold	3,200	–	–	﹤0.01%	1692
2024 Q4	$4.9K	Hold	3,200	–	–	﹤0.01%	1722
2024 Q3	$6.37K	Hold	3,200	–	–	﹤0.01%	1677
2024 Q2	$11.2K	Hold	3,200	–	–	﹤0.01%	1528
2024 Q1	$9.01K	Hold	3,200	–	–	﹤0.01%	1070
2023 Q4	$5.44K	Sell	3,200 -3,200	-50%	-$3.52K	﹤0.01%	1155
2023 Q3	$6.59K	Buy	6,400 +3,200	+100%	+$4.55K	﹤0.01%	1176
2023 Q2	$3.71K	Buy	3,200 +1,800	+129%	+$3.21K	﹤0.01%	1078
2023 Q1	$2.11K	Hold	1,400	–	–	﹤0.01%	1128
2022 Q4	$3.5K	Hold	1,400	–	–	﹤0.01%	1023
2022 Q3	$6K	Hold	1,400	–	–	﹤0.01%	952
2022 Q2	$4K	Hold	1,400	–	–	﹤0.01%	1029
2022 Q1	$8K	Hold	1,400	–	–	﹤0.01%	1016
2021 Q4	$13K	Hold	1,400	–	–	﹤0.01%	894
2021 Q3	$15K	Hold	1,400	–	–	﹤0.01%	881
2021 Q2	$22K	Hold	1,400	–	–	﹤0.01%	693
2021 Q1	$23K	Hold	1,400	–	–	﹤0.01%	651
2020 Q4	$30K	Hold	1,400	–	–	﹤0.01%	575
2020 Q3	$21K	Hold	1,400	–	–	﹤0.01%	578
2020 Q2	$21K	Hold	1,400	–	–	﹤0.01%	521
2020 Q1	$16K	Buy	+1,400	New	+$26.3K	﹤0.01%	525

Other funds holding HRTX